Alterity Therapeutics
Open
$4.60
Prev. Close
$4.57
High
$4.60
Low
$4.60
Market Snapshot
$83.24M
-8.60
$10.74M
9
The company is headquartered in Melbourne, Victoria and currently employs 9 full-time employees. The company went IPO on 2000-03-28.
emptyResult
The company is headquartered in Melbourne, Victoria and currently employs 9 full-time employees. The company went IPO on 2000-03-28.
Recently from Cashu
Alterity Therapeutics Advances Innovative Treatments for Neurodegenerative Diseases with PBT2
Alterity Therapeutics Seeks to Enhance Neurodegenerative Disease Treatments Through Innovative Approaches Alterity Therapeutics, a clinical-stage biotechnology company, focuses on developing novel the…
Alterity Therapeutics Advances ATH-1017 for Neurodegenerative Disease Treatment and Research Expansion
Alterity Therapeutics Advances in Neurodegenerative Disease Treatment Alterity Therapeutics makes significant strides in the treatment of neurodegenerative diseases, particularly focusing on alpha-syn…
Alterity Therapeutics Advances PBT434 in Neurodegenerative Disease Research and Treatment
Alterity Therapeutics Advances in Neurodegenerative Disease Research Alterity Therapeutics, a clinical-stage biotechnology company, focuses on developing innovative therapies for neurodegenerative dis…
Alterity Therapeutics Reports Promising Progress in Neurodegenerative Disease Trials with ATH434
### Alterity Therapeutics Advances in Neurodegenerative Disease Research Alterity Therapeutics, a biopharmaceutical company focused on developing therapies for neurodegenerative diseases, announces si…